Clinical Trial Update: Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating Cycloset (bromocriptine) 0.8 mg tablets in children and adolescents with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CYCLOSET (BROMOCRIPTINE MESYLATE)

Snippet

Sponsor: VeroScience | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED